Ahmad Mehravaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmad Mehravaran has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Hadi Mirahmadi
Department of Parasitology and Mycology, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
4 shared publications- Hadi Mirahmadi
Infectious Disease and Tropical Medicine Research Center, Resistance Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran
4 shared publications Javad Akhtari
Toxoplasmosis Research Center, Department of Medical Nanotechnology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
4 shared publicationsAmin Reza Nikpoor
Immunogenetic and Cell Culture Department, Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publicationsEbrahim Alijani
Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
2 shared publicationsIraj Sharifi
Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran
2 shared publications
Latest Publications
- Open Access
- 28 April 2025
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 53 (1) , 1-14
Green synthesis of PEGylated iron oxide nanoparticles of Eriobotrya japonica leaves extract in combination with B3, against Plasmodium falciparum 3D7 strain
Background: Plasmodium falciparum represents the most prevalent and lethal protozoan responsible for malaria in humans. This investigation aims to synthesize iron nanoparticles utilizing the polyethylene glycol (PEG) synthesis approach with an Eriobotrya japonica leaves extract and investigating its anti- P. falciparum activity in the in vitro environment in combination with nicotinamide and comparing its effect with chloroquine. Methods: Iron oxide nanoparticles were synthesized using Eriobotrya japonica leaf extract through a green synthesis method. The physicochemical properties of the nanoparticles were analyzed using DLS, FESEM, FTIR, XRD, and MTT assays. During the initial phase, varying concentrations of Japanese parsnip leaf extract, nicotinamide, iron nanoparticles synthesized through the PEGylated green synthesis technique, and chloroquine (as a control pharmacological agent) were individually administered to the culture medium of P. falciparum 3D7. Subsequently, the synergistic IC50 effects of these compounds were evaluated in relation to one another using the FIX RATIO methodology applied to the culture medium. Results: The DLS evaluation of iron oxide nanoparticles showed an average hydrodynamic size of 155 nm. The XRD examination exhibited the crystallinity of the particles. SEM images recognized the spherical nature of synthesized Fe3O4 nanoparticles. The relative combination of plant extract–nicotinamide had a synergistic effect and the best dose was observed in 70% plant extract–30% nicotinamide, resulting in a 70% reduction in parasitic load. The most pronounced growth-inhibitory effect was observed in the formulation comprising 50% PEGylated green synthesized Fe3O4 nanoparticles and 50% nicotinamide, yielding a 73% inhibition rate. Conclusions: The presence of a synergistic effect was evident across all combinations of plant extract–nicotinamide and iron oxide nanoparticles synthesized through the PEGylated green synthesis approach. Furthermore, the methodologies of green synthesis and PEGylation of iron oxide nanoparticles are deemed effective strategies for enhancing stability, minimizing toxicity, reducing particle size, and facilitating improved precision and efficacy in the application of these entities within biomedical research contexts.
- 28 April 2025
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 53 (1) , 1-14
Open AccessGreen synthesis of PEGylated iron oxide nanoparticles of Eriobotrya japonica leaves extract in combination with B3, against Plasmodium falciparum 3D7 strain
Background: Plasmodium falciparum represents the most prevalent and lethal protozoan responsible for malaria in humans. This investigation aims to synthesize iron nanoparticles utilizing the polyethylene glycol (PEG) synthesis approach with an Eriobotrya japonica leaves extract and investigating its anti- P. falciparum activity in the in vitro environment in combination with nicotinamide and comparing its effect with chloroquine. Methods: Iron oxide nanoparticles were synthesized using Eriobotrya japonica leaf extract through a green synthesis method. The physicochemical properties of the nanoparticles were analyzed using DLS, FESEM, FTIR, XRD, and MTT assays. During the initial phase, varying concentrations of Japanese parsnip leaf extract, nicotinamide, iron nanoparticles synthesized through the PEGylated green synthesis technique, and chloroquine (as a control pharmacological agent) were individually administered to the culture medium of P. falciparum 3D7. Subsequently, the synergistic IC50 effects of these compounds were evaluated in relation to one another using the FIX RATIO methodology applied to the culture medium. Results: The DLS evaluation of iron oxide nanoparticles showed an average hydrodynamic size of 155 nm. The XRD examination exhibited the crystallinity of the particles. SEM images recognized the spherical nature of synthesized Fe3O4 nanoparticles. The relative combination of plant extract–nicotinamide had a synergistic effect and the best dose was observed in 70% plant extract–30% nicotinamide, resulting in a 70% reduction in parasitic load. The most pronounced growth-inhibitory effect was observed in the formulation comprising 50% PEGylated green synthesized Fe3O4 nanoparticles and 50% nicotinamide, yielding a 73% inhibition rate. Conclusions: The presence of a synergistic effect was evident across all combinations of plant extract–nicotinamide and iron oxide nanoparticles synthesized through the PEGylated green synthesis approach. Furthermore, the methodologies of green synthesis and PEGylation of iron oxide nanoparticles are deemed effective strategies for enhancing stability, minimizing toxicity, reducing particle size, and facilitating improved precision and efficacy in the application of these entities within biomedical research contexts.
- Open Access
- 1 January 2025
- Vol. 28 (3) , 347-354
Protective immune response induced by cationic liposomes bearing soluble antigens improves the survival of BALB/c mice against Toxoplasma gondii RH strain
An ideal strategy to control acute or chronic toxoplasmosis can be the development and production of an effective vaccine. Liposomes as immunoadjuvants may be utilized to boost immune reactions for various antigens. In this study, we encapsulated soluble Toxoplasma antigen (SA) in 1, 2-Dioleoyl-3-trimethylammonium propane (DOTAP) liposomes to assess the elicited immunological response. BALB/C mice received three intramuscular injections of various formulations separated by two weeks. The kind of immune reaction that was created, the degree of protection, the percentage of BALB/c mice that survived the Toxoplasma gondii challenge, the immune reaction assessment with cytokine synthesis (IFN-γ, IL-4), and the titration of IgG isotypes were all evaluated. Compared to other groups, the liposome DOTAP + imiquimod + SA-immunized mice showed a significantly lower death rate (P<0.01). Liposome DOTAP + Imiquimod + SA had higher IgG2a and IFN-γ secretion levels than the control group (P<0.001 and P<0.0001, respectively). According to the study’s findings, the liposome DOTAP + imiquimod + SA formulation generates a cellular immunological response, making it resistant to the T. gondii challenge.
- 1 January 2025
- Vol. 28 (3) , 347-354
Open AccessProtective immune response induced by cationic liposomes bearing soluble antigens improves the survival of BALB/c mice against Toxoplasma gondii RH strain
An ideal strategy to control acute or chronic toxoplasmosis can be the development and production of an effective vaccine. Liposomes as immunoadjuvants may be utilized to boost immune reactions for various antigens. In this study, we encapsulated soluble Toxoplasma antigen (SA) in 1, 2-Dioleoyl-3-trimethylammonium propane (DOTAP) liposomes to assess the elicited immunological response. BALB/C mice received three intramuscular injections of various formulations separated by two weeks. The kind of immune reaction that was created, the degree of protection, the percentage of BALB/c mice that survived the Toxoplasma gondii challenge, the immune reaction assessment with cytokine synthesis (IFN-γ, IL-4), and the titration of IgG isotypes were all evaluated. Compared to other groups, the liposome DOTAP + imiquimod + SA-immunized mice showed a significantly lower death rate (P<0.01). Liposome DOTAP + Imiquimod + SA had higher IgG2a and IFN-γ secretion levels than the control group (P<0.001 and P<0.0001, respectively). According to the study’s findings, the liposome DOTAP + imiquimod + SA formulation generates a cellular immunological response, making it resistant to the T. gondii challenge.
- Open Access
- 30 July 2024
- Published by Brieflands in International Journal of Infection
- Vol. 11 (2)
Frequency of Trichomonas vaginalis in Pap Smears of Women Referring to the Gynecology Clinics in Zahedan from 2013 to 2022
Background: Trichomoniasis, caused by Trichomonas vaginalis, is a common sexually transmitted disease that can lead to complications such as vaginitis, pelvic infections, preterm delivery, and increased risks of HIV and HPV transmission. Women often experience foul-smelling discharge and inflammatory symptoms, though about half of cases are asymptomatic. Various diagnostic methods, including Pap smears, are used for detection. Objectives: This study investigated the prevalence of trichomoniasis among women referred to gynecology clinics in Zahedan using Pap smear testing. Methods: This descriptive, cross-sectional, retrospective study was conducted based on the records of 20,607 pregnant women and those coming for periodic checkups referred to gynecology clinics under the coverage of Zahedan University of Medical Sciences in Zahedan from 2013 to 2022. The data included influential factors such as age, number of pregnancies, contraceptive methods, and number of abortions and were analyzed using the chi-square test. Results: A ten-year study involving 20,607 patients found the prevalence of trichomoniasis with 103 positive cases. Of those, 69.9% showed inflammation, 75.7% had fungal infections, and 22.35% had bacterial infections. The highest infection rates were in women aged 35 to 45 years, particularly those with three to five pregnancies using fallopian tube ligation. Significant associations were found between age, number of pregnancies, contraceptive method, and infection prevalence (P < 0.05), along with a significant relationship between inflammation and trichomoniasis (P = 0.007). Conclusions: This study reveals that trichomoniasis prevalence in Zahedan is relatively low compared to other studies. More research and better health information about symptoms and transmission are needed. It is also important to examine the infection's prevalence in men and use accurate diagnostic methods to avoid misdiagnosis. Educating women about the risks of sexually transmitted infections can help reduce prevalence.
- 30 July 2024
- Published by Brieflands in International Journal of Infection
- Vol. 11 (2)
Open AccessFrequency of Trichomonas vaginalis in Pap Smears of Women Referring to the Gynecology Clinics in Zahedan from 2013 to 2022
Background: Trichomoniasis, caused by Trichomonas vaginalis, is a common sexually transmitted disease that can lead to complications such as vaginitis, pelvic infections, preterm delivery, and increased risks of HIV and HPV transmission. Women often experience foul-smelling discharge and inflammatory symptoms, though about half of cases are asymptomatic. Various diagnostic methods, including Pap smears, are used for detection. Objectives: This study investigated the prevalence of trichomoniasis among women referred to gynecology clinics in Zahedan using Pap smear testing. Methods: This descriptive, cross-sectional, retrospective study was conducted based on the records of 20,607 pregnant women and those coming for periodic checkups referred to gynecology clinics under the coverage of Zahedan University of Medical Sciences in Zahedan from 2013 to 2022. The data included influential factors such as age, number of pregnancies, contraceptive methods, and number of abortions and were analyzed using the chi-square test. Results: A ten-year study involving 20,607 patients found the prevalence of trichomoniasis with 103 positive cases. Of those, 69.9% showed inflammation, 75.7% had fungal infections, and 22.35% had bacterial infections. The highest infection rates were in women aged 35 to 45 years, particularly those with three to five pregnancies using fallopian tube ligation. Significant associations were found between age, number of pregnancies, contraceptive method, and infection prevalence (P < 0.05), along with a significant relationship between inflammation and trichomoniasis (P = 0.007). Conclusions: This study reveals that trichomoniasis prevalence in Zahedan is relatively low compared to other studies. More research and better health information about symptoms and transmission are needed. It is also important to examine the infection's prevalence in men and use accurate diagnostic methods to avoid misdiagnosis. Educating women about the risks of sexually transmitted infections can help reduce prevalence.
- Open Access
- 1 June 2021
- Vol. 8 (3) , 179-186
Evaluation of survival rate using liposome containing soluble antigens (SA) against Toxoplasma gondii infection in BALB/c mice
- 1 June 2021
- Vol. 8 (3) , 179-186
Open AccessEvaluation of survival rate using liposome containing soluble antigens (SA) against Toxoplasma gondii infection in BALB/c mice
- Open Access
- 1 August 2019
- Vol. 22 (8) , 922-931
Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice
Objective(s): Protection against leishmaniasis, in the murine model, is dependent on developing a potent CD4+ mediated Th1 type response. Liposomes can be applied as immunoadjuvants to stimulate immune responses to different antigens. In the present study, it was investigated whether DOTAP liposomes having SLA and imiquimod adjuvant, can induce a Th1 response and protect against Leishmania major challenge in BALB/c mice. Materials and Methods: Liposomes were provided applying the lipid film procedure. BALB/C mice were subcutaneously immunized, three times with 2-week intervals, with various formulations. Assessment of lesion development and parasite burden in the foot and spleen after challenge with L. major, assessment of Th1 cytokine (IFN-γ), and titration of IgG isotypes assessed the type of generated immune reaction and the protection extent. Results: The mice immunized with Liposome DOTAP+imiquimod+SLA showed smaller footpad swelling which was meaningfully different (P<0.05) compared with other groups. The highest level of IgG2a was observed with Lip DOTAP+imiquimod+SLA more than the control (P<0.001). Mice immunized with Lip DOTAP+SLA+imiquimod demonstrated the least number of live parasites in the footpad and spleen. Cytokine assay showed that the greatest IFN- γ secretion was seen in the splenocytes of mice immunized with all formulations as compared to the control group (P<0.0001). In contrast, the lowest IL-4 production was detectable in Lip+imiquimod+SLA spleen, which was not significantly different compared with other groups.Conclusion: The results of this study show that liposome DOTAP+SLA+imiquimod formulation generates a cellular immune response that is protective against challenge against L. major.
- 1 August 2019
- Vol. 22 (8) , 922-931
Open AccessImmunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice
Objective(s): Protection against leishmaniasis, in the murine model, is dependent on developing a potent CD4+ mediated Th1 type response. Liposomes can be applied as immunoadjuvants to stimulate immune responses to different antigens. In the present study, it was investigated whether DOTAP liposomes having SLA and imiquimod adjuvant, can induce a Th1 response and protect against Leishmania major challenge in BALB/c mice. Materials and Methods: Liposomes were provided applying the lipid film procedure. BALB/C mice were subcutaneously immunized, three times with 2-week intervals, with various formulations. Assessment of lesion development and parasite burden in the foot and spleen after challenge with L. major, assessment of Th1 cytokine (IFN-γ), and titration of IgG isotypes assessed the type of generated immune reaction and the protection extent. Results: The mice immunized with Liposome DOTAP+imiquimod+SLA showed smaller footpad swelling which was meaningfully different (P<0.05) compared with other groups. The highest level of IgG2a was observed with Lip DOTAP+imiquimod+SLA more than the control (P<0.001). Mice immunized with Lip DOTAP+SLA+imiquimod demonstrated the least number of live parasites in the footpad and spleen. Cytokine assay showed that the greatest IFN- γ secretion was seen in the splenocytes of mice immunized with all formulations as compared to the control group (P<0.0001). In contrast, the lowest IL-4 production was detectable in Lip+imiquimod+SLA spleen, which was not significantly different compared with other groups.Conclusion: The results of this study show that liposome DOTAP+SLA+imiquimod formulation generates a cellular immune response that is protective against challenge against L. major.
- Open Access
- 1 June 2019
- Vol. 7 (1) , 29-39
Liposomes containing the imiquimod adjuvant as a vaccine in the cutaneous leishmaniasis model
- 1 June 2019
- Vol. 7 (1) , 29-39
Open AccessLiposomes containing the imiquimod adjuvant as a vaccine in the cutaneous leishmaniasis model
- Open Access
- 26 May 2018
- Published by Veterinary World in Veterinary World
- Vol. 11 (5) , 700-705
Detection of species and molecular typing of Leishmania in suspected patients by targeting cytochrome b gene in Zahedan, southeast of Iran
This cross-sectional study aimed to differentiate the species that are able to cause CL in Zahedan city by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method
- 26 May 2018
- Published by Veterinary World in Veterinary World
- Vol. 11 (5) , 700-705
Open AccessDetection of species and molecular typing of Leishmania in suspected patients by targeting cytochrome b gene in Zahedan, southeast of Iran
This cross-sectional study aimed to differentiate the species that are able to cause CL in Zahedan city by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method
- Open Access
- 18 September 2017
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 10 (10)
The Incidence of Current Infection with Different Human Malaria Species by Polymerase Chain Reaction for Diagnosis of Suspicious Malaria Patients on Elimination Region Sistan and Baluchistan Province, Southeast of Iran
Background: Malaria, as a parasitic disease, is one of the most important public health problems in Iran. Malaria is mainly diagnosed by peripheral blood smear, stained by Giemsa; in Iran it is also diagnosed by blood smear that is highly depends on technician’s skills and laboratory properties. Objectives: Correct diagnosis of malaria and identification of human malaria species in spite of the measures taken to eliminate the disease in Iran, have made the complete understanding of malaria epidemiology critical. Therefore, the current study aimed at investigating the epidemiology of 2 species of human Plasmodium in Sistan and Baluchistan province using polymerase chain reaction (PCR) method. Methods: The present descriptive study was conducted on 100 patients suspected to malaria infection who referred to health centers of Chabahar, Iranshahr, Nikshahr, and Sarbaz districts. DNAs were extracted from blood samples using the specific kit, and nested-PCR reaction was performed to identify the Plasmodium species according to NP-2013 protocol. Results: Molecular analysis was performed on 100 samples suspected of malaria; 84 negative and 16 positive samples were detected including 8 Plasmodium vivax, 2 P. falciparum, and 6 mixed infections (P. vivax and P. falciparum). No P. ovale or P. malariae was observed. Conclusions: The results showed that malaria had a decreasing trend in Sistan and Baluchistan province. Therefore, the malaria elimination program is applicable and attainable in this region as a goal. Keywords: Malaria; Plasmodium Species; Nested-PCR; Iran; Plasmodium vivax; P. falciparum
- 18 September 2017
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 10 (10)
Open AccessThe Incidence of Current Infection with Different Human Malaria Species by Polymerase Chain Reaction for Diagnosis of Suspicious Malaria Patients on Elimination Region Sistan and Baluchistan Province, Southeast of Iran
Background: Malaria, as a parasitic disease, is one of the most important public health problems in Iran. Malaria is mainly diagnosed by peripheral blood smear, stained by Giemsa; in Iran it is also diagnosed by blood smear that is highly depends on technician’s skills and laboratory properties. Objectives: Correct diagnosis of malaria and identification of human malaria species in spite of the measures taken to eliminate the disease in Iran, have made the complete understanding of malaria epidemiology critical. Therefore, the current study aimed at investigating the epidemiology of 2 species of human Plasmodium in Sistan and Baluchistan province using polymerase chain reaction (PCR) method. Methods: The present descriptive study was conducted on 100 patients suspected to malaria infection who referred to health centers of Chabahar, Iranshahr, Nikshahr, and Sarbaz districts. DNAs were extracted from blood samples using the specific kit, and nested-PCR reaction was performed to identify the Plasmodium species according to NP-2013 protocol. Results: Molecular analysis was performed on 100 samples suspected of malaria; 84 negative and 16 positive samples were detected including 8 Plasmodium vivax, 2 P. falciparum, and 6 mixed infections (P. vivax and P. falciparum). No P. ovale or P. malariae was observed. Conclusions: The results showed that malaria had a decreasing trend in Sistan and Baluchistan province. Therefore, the malaria elimination program is applicable and attainable in this region as a goal. Keywords: Malaria; Plasmodium Species; Nested-PCR; Iran; Plasmodium vivax; P. falciparum
- 1 December 2015
- Vol. 12 (4) , 274-87
Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation.
Cationic immune stimulating complexes (PLUSCOMs) are particulate antigen delivery systems. PLUSCOMs consist of cationic immunostimulatory complexes (ISCOMs) derivatives and are able to elicit in vivo T cell responses against an antigen. To evaluate the effects of PLUSCOMs containing Leishmania major antigens (SLA) on the type of immune response generated in the murine model of leishmaniasis. PLUSCOMs consisting of 1, 2-dioleoyl-3-trimethylammonium-propane (DOTAP) were used as antigen delivery system/immunoadjuvants for soluble SLA. BALB/c mice were immunized subcutaneously, three times in 2-week intervals. Footpads swellings at the site of challenge and parasite loads were assessed as a measure of protection. The immune responses were also evaluated by determination of IgG subclasses and the level of IFN-γ and IL-4 in cultured splenocytes. There was no significant difference (p<0.05) between the sizes of lesions in mice immunized with different formulations. Also, there was no significant difference in the number of parasites in the footpad or spleen of all groups compared with the control group. The highest level of IFN-γ secretion was observed in the splenocytes of mice immunized with PLUSCOM/SLA (p<0.001) and lower amounts of IL-4 was observed in PLUSCOM group (p<0.001) as compared to negative control. Our results indicated that SLA in different formulations generated an immune response with mixed Th1/Th2 response that was not protective enough despite the activation of CD4+ T cells with secreting IFN-γ in groups which received PLUSCOM with antigen.
- 1 December 2015
- Vol. 12 (4) , 274-87
Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation.
Cationic immune stimulating complexes (PLUSCOMs) are particulate antigen delivery systems. PLUSCOMs consist of cationic immunostimulatory complexes (ISCOMs) derivatives and are able to elicit in vivo T cell responses against an antigen. To evaluate the effects of PLUSCOMs containing Leishmania major antigens (SLA) on the type of immune response generated in the murine model of leishmaniasis. PLUSCOMs consisting of 1, 2-dioleoyl-3-trimethylammonium-propane (DOTAP) were used as antigen delivery system/immunoadjuvants for soluble SLA. BALB/c mice were immunized subcutaneously, three times in 2-week intervals. Footpads swellings at the site of challenge and parasite loads were assessed as a measure of protection. The immune responses were also evaluated by determination of IgG subclasses and the level of IFN-γ and IL-4 in cultured splenocytes. There was no significant difference (p<0.05) between the sizes of lesions in mice immunized with different formulations. Also, there was no significant difference in the number of parasites in the footpad or spleen of all groups compared with the control group. The highest level of IFN-γ secretion was observed in the splenocytes of mice immunized with PLUSCOM/SLA (p<0.001) and lower amounts of IL-4 was observed in PLUSCOM group (p<0.001) as compared to negative control. Our results indicated that SLA in different formulations generated an immune response with mixed Th1/Th2 response that was not protective enough despite the activation of CD4+ T cells with secreting IFN-γ in groups which received PLUSCOM with antigen.